<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-06T00:50:01Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/45417" metadataPrefix="qdc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/45417</identifier><datestamp>2026-04-10T09:19:47Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><qdc:qualifieddc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Dendrimeric antigens for passive mast cell activation in the evaluation of amoxicillin allergy</dc:title>
   <dc:creator>Tesfaye Ayane, Amene</dc:creator>
   <dc:creator>Salas, María</dc:creator>
   <dc:creator>Benede, Sara</dc:creator>
   <dc:creator>Rodríguez-Sánchez, Maria J.</dc:creator>
   <dc:creator>Rodríguez-Sojo, María J.</dc:creator>
   <dc:creator>Jiménez-Sánchez, Isabel M.</dc:creator>
   <dc:creator>Bogas, Gador</dc:creator>
   <dc:creator>Pérez-de-Inestrosa-Villatoro, Ezequiel</dc:creator>
   <dc:creator>Mayorga, Cristobalina</dc:creator>
   <dc:creator>Paris, Juan L.</dc:creator>
   <dc:creator>Rodríguez-Nogales, Alba</dc:creator>
   <dc:creator>Torres-Jaén, María Josefa</dc:creator>
   <dc:creator>Montañez-Vega, María Isabel</dc:creator>
   <dc:subject>Antibióticos</dc:subject>
   <dc:subject>Alergia a los medicamentos</dc:subject>
   <dc:subject>Antibióticos betalactámicos</dc:subject>
   <dc:subject>Amoxicilina</dc:subject>
   <dcterms:abstract>Background: Amoxicillin (AX) is frequently implicated in immediate IgE-mediated allergic reactions. Diagnosis is challenging,highlighting the need for new approaches enhancing in vitro sensitivity and specificity. Engineered nanostructures can mimicimmunological recognition of hapten-carrier conjugates, offering a strategy to improve diagnostic accuracy.Methods: Dendrimeric Antigens (DeAns), with controlled size (1st–5th generation) and multivalent AX determinants (8–128 units, respectively), were synthesized for in vitro immunological evaluation. In vitro IgE recognition was studied by com-petitive radio-immunoassay. Allergenic activity was evaluated in mouse bone marrow-derived mast cells (MC) sensitized withmouse anti-AX IgE monoclonal antibody and humanized RBL-2H3 (huRBL-2H3) and LUVA cells sensitized with sera fromβ-lactam-allergic subjects and tolerant controls, measuring degranulation in response to DeAns stimulation.Results: Five different DeAns were obtained as pure compounds. All DeAns were recognized by AX-sIgE. A clear size-dependent activation pattern was observed in the three cell models: lower-generation (1st–2nd) DeAns failed to induce degranu-lation, whereas DeAns of bigger size (3rd–5th generation) triggered significant, dose-dependent activation. Notably, no activationwas observed in tolerants and unsensitized cells or with blank dendrimers. In patient-sera assays, the passive MC activation test(pMAT) with DeAns provided complete diagnostic discrimination, with activation restricted to AX-allergic patients.Conclusions: DeAns are effective platforms for investigating effector cell activation in AX allergy. By fine-tuning structuralattributes—size and multivalence—we reveal the promising utility of DeAns in pMAT that leverage commercial cell lines andpatient sera. This approach could address key limitations of β-lactam allergy diagnostics, enabling more reliable and standard-ized in vitro testing.</dcterms:abstract>
   <dcterms:issued>2026</dcterms:issued>
   <dc:type>journal article</dc:type>
   <dc:identifier>A. T. Ayane, M. Salas, S. Benede, et al., “ Dendrimeric Antigens for Passive Mast Cell Activation in the Evaluation of Amoxicillin Allergy,” Allergy (2026): 1–12, https://doi.org/10.1111/all.70250.</dc:identifier>
   <dc:identifier>https://hdl.handle.net/10630/45417</dc:identifier>
   <dc:identifier>https://doi.org/10.1111/all.70250</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>info:eu-repo/grantAgreement/EC/H2020/713721/EU</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/AC19%2F00082/ES/NANODIAGNOSTICO PARA LA HIPERSENSIBILIDAD A BETALACTAMICOS/</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F01237/ES/APLICACION DE NANOARQUITECTURAS SINTETICAS AL ESTUDIO DE LOS MECANISMOS DE ACTIVACION DEL BASOFILO Y AL DIAGNOSTICO EN REACCIONES ALERGICAS A AMOXICILINA./</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI21%2F00329/ES/OPTIMIZACION DIAGNOSTICA EN ALERGIA A BETALACTAMICOS: DE LA ESTANDARIZACIÓN Y RACIONALIZACIÓN DE LAS PRUEBAS IN VIVO, AL DESARROLLO DE TEST IN VITRO INNOVADORES BASADOS EN NANOTECNOLOGIA Y METABOLÓMICA./</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F01734/ES/NANOARQUITECTURAS ALTAMENTE EFICIENTES PARA UN ENTRECRUZAMIENTO EFICAZ DE LA IGE EN MASTOCITOS Y BASOFILOS. APLICACION AL DIAGNOSTICO DE REACCIONES ALERGICAS A AMOXICILINA Y ACIDO CLAVULANICO./</dc:relation>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:publisher>Wiley</dc:publisher>
</qdc:qualifieddc>
</metadata></record></GetRecord></OAI-PMH>